Fill Out Your Profile to share more about you. Learn more...

Tukysa + Standard Care Improves Survival for HER2+ Brain Mets

Options

Tukysa Plus Standard Care Improves Survival in People With HER2-Positive Brain Mets
Feb 27, 2023

Tukysa plus the standard of care improved survival in people diagnosed with metastatic, HER2-positive breast cancer that had spread to the brain. Read more...